Latest Articles • Benzinga

Dutch Bros Stock Climbs After Better-Than-Expected Q1 Report

Dutch Bros releases its first-quarter results after Wednesday's closing bell. Here's a look at the key figures from the quarter.

AppLovin Stock Shakes Off Short Seller Report, Shares Surge On Q1 Earnings Beat

AppLovin reports first-quarter revenue of $1.48 billion, beating analyst estimates of $1.38 billion, according to Benzinga Pro. The company reports first-quarter earnings of $1.67 per share, beating analyst estimates of $1.45 per share.

IonQ Q1 Earnings: Revenue Beat, Smaller-Than-Expected Loss, Forward Guidance And More

IonQ Inc (NYSE:IONQ) reported financial results for the first quarter Wednesday after the market close. Here's an overview of the quantum computing company's report.

Fortinet Stock Sinks After Q1 Results: Earnings Beat, Revenues In-Line

Fortinet releases its first-quarter results after Wednesday's closing bell. Here's a look at the key figures from the report.

Sunrun Stock Rallies After Strong Q1 Report: Details

Sunrun released its first-quarter results after Wednesday's closing bell. Here's a look at the key figures from the report:

Carvana Q1 Earnings: Revenue, EPS Beat Estimates As Vehicles Sales Jump 46%, Company Remains On Track For 'Significant Growth' In FY25

Carvana reports first-quarter revenue of $4.23 billion, beating the consensus estimate of $3.98 billion. The company reports first-quarter earnings of $1.51 per share, smashing analyst estimates of 60 cents per share.

Arm Holdings Stock Plunges After Q4 Results: Here's Why

Arm Holdings releases its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report.

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Chardan initiates Bright Minds with a Buy rating, citing over $1 billion sales potential for epilepsy drug BMB-101 despite limited clinical data.

What's Going On With Opendoor Shares Wednesday?

Opendoor stock trades lower Wednesday after the company reports first-quarter earnings on Tuesday after the market closed.

MrBeast Is The Richest YouTuber In The World, But Says 'I'm Like A Zoo Animal' With No Free Will — 'No One Wants To Live The Life I Live'

AMC Q1 Earnings Highlights: Double Beat, CEO Highlights 2025, 2026 Slate As Box Office Doubles In April

Movie theater company AMC reported Q1 financial results Wed. May 7. Here are the key highlights and a look at what's next.

Clover Health Shares Surge After Strong Q1 Earnings, Now Up 409% Over Past Year

Clover Health Investments saw its shares jump more than 12% on Wednesday. Following better-than-expected profitability in the first-quarter, despite missing revenue estimates.

Options Corner: Cinemark's Short Squeeze Won't Prevent The Credits From Eventually Rolling

While Cinemark may be a beneficiary of short-squeeze speculation, CNK stock may eventually fade, opening the door for a bearish strategy.

Arista's Stock Hit As Analysts Cut Targets Over Tariff Uncertainty Despite Strong AI Demand

Arista Networks (NYSE: ANET) stock dropped after analysts lowered price targets. EPS beat estimates, but outlook remains conservative due to tariff uncertainty.

Alibaba Stock Drops After US Lawmakers Push For Delisting

Alibaba shares are trading lower Wednesday after two senior U.S. lawmakers called on the Securities and Exchange Commission (SEC) to delist it along with other Chinese companies.

Celsius Stock Slips After Q1 Miss, But Analyst Sees Strong Long-Term Growth Drivers

JPMorgan analyst Andrea Teixeira reiterated the Overweight rating on Celsius Holdings on Wednesday, with a price forecast of $44.

Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals

Tempus AI shares rose after a Q1 beat, as an analyst highlighted its AI-driven growth, expanding pharma deals, and $1B+ contract value.

Palantir (PLTR) Shares Fall Despite Strong Q1 Earnings, Raised Guidance: What's Going On?

Palantir Technologies shares are down 11.4% this week. The stock is down despite Palantir delivering solid first-quarter results and lifting its full-year outlook.